Aktiesnakken — Juli 2010
-
og vigtigere har du ekstra batteri
-
på cd38 og zalutumumab
-
cd38 er meget early stage, så der vil jeg tro at vi ligger på mellem 50-200 mill upfront deal med fuldfede royalties
-
zalutumumab tror jeg de laver et ordentligt nummer på. Jeg tror de sælger det sammen med fabrikken for 1,2 milliarder
-
og igen fuld fede royalties
-
de ender med over 3 milliarder i kassen!
-
hej pete! der løber nu et rygte, som jeg har sat igang, at Genmab nu tjener flere penge end de bruger
-
jeg giver hele pi budweisere i kurs 300
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind